At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LGVN Longeveron Inc
Trading 05-16 10:01:35 EDT
1.34
+0.00
0.00%
High1.35
Low1.31
Vol43.07K
Open1.35
D1 Closing1.34
Amplitude2.99%
Mkt Cap8.51M
Tradable Cap5.77M
Total Shares6.35M
T/O57.17K
T/O Rate1.00%
Tradable Shares4.31M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Longeveron GAAP EPS of -$1.61 beats by $0.39, revenue of $0.55M beats by $0.49M
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, a candidate in Phase 2a/b trials that is used for the treatment of alzheimer's disease, hypoplastic left heart syndrome, and aging-related frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.